S04.1 Disease activity and clinical remission in systemic lupus erythematosus: comparison between patient and physician perspectives by means of patient reported outcomes (PROS) by L Andreoli, F Franceschini, M Fredi, C Bazzani, M Salvi, C Orlandi, C Nalli

Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? by A. Tincani, I. Cavazzana, A. Ceribelli, M. Fredi, F. Inverardi, M. Taraborelli, F. Franceschini

Get full text

The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus by M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani

Get full text

Typing TREX1 gene in patients with systemic lupus erythematosus by M. Fredi, M. Bianchi, L. Andreoli, G. Greco, I. Olivieri, S. Orcesi, E. Fazzi, C. Cereda, A. Tincani

Get full text

PO.3.56 Anti- Ro/SSA antibodies and electrocardiographic abnormalities in SLE patients: preliminary data of a multidisciplinary study in a monocentric cohort by F Franceschini, M Fredi, S Bertocchi, E Pedretti, R Rovelli, L Serafini, A Drera, M Riccardi, F Ravasio, E Vizzardi

Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center by F. Dall'Ara, I. Cavazzana, M. Frassi, M. Taraborelli, M. Fredi, F. Franceschini, L. Andreoli, M. Rossi, C. Cattaneo, A. Tincani, P. Airò

Get full text

PO.6.133 Dynamical trajectory of glucocorticoid tapering and discontinuation in real-world patients with newly diagnosed systemic lupus erythematosus: the gulp study by F Franceschini, M Fredi, F Conti, F Iannone, FR Spinelli, M Govoni, A Doria, M Mosca, L Iaccarino, F Bellisai, A Cauli, C Tani, M Piga, I Prevete, GD Sebastiani, E Chessa, A Floris, L Coladonato, A Bortoluzzi, R D’Alessandro, A Zanetti, G Carrara, CA Scirè